Motley Fool90d agoneutral
Pfizer's Earnings Have Declined 58% This Year. Is a Dividend Cut Around the Corner?Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
GuruFocus.com94d agoneutral
Novavax Inc (NVAX) (Q2 2026) Earnings Call Highlights: Matrix-M Momentum Drives Revenue ...Simply Wall St.95d agoneutral
Pfizer (PFE) Could Be 12% Undervalued Following Raised 2026 Revenue GuidanceBioPharma Dive95d agoneutral
Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launchPharmaceutical Technology96d agobearish
Pfizer repels Covid-19 sales tumble to raise 2026 guidanceInvestor's Business Daily96d agobearish
Pfizer Hikes 2026 Sales Outlook By $500 Million On Second-Quarter BeatThe Wall Street Journal96d agobullish
Pfizer’s Quarterly Results Beat Expectations on Cancer, Heart DrugsBarrons.com96d agoneutral
AstraZeneca-Bristol Myers: The Floodgates for Biotech Mergers Are Open